The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
Trial details
- Registry ID
- NCT03129126
- Drugs studied
- LP-10
TrialRedline tracks 2 clinical trials sponsored by Lipella Pharmaceuticals, Inc.: 2 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic CystitisNCT03129126 | LP-10 | Completed | 2023-08-21Actual |
| Evaluating LP-10 in Subjects With OLPNCT06233591 | LP-10 (Liposomal Tacrolimus) | Unknown | 2025-06-01Estimated |
Names as written in the registry records.